Archive for June, 2008

The Statin Showdown

A complex scientific debate underpins the controversy over cholesterol drugs.

Analyst Says Bristol-Myers A Buyout Target

Could a take-out be in the pharma company's future? If so Pfizer is the ideal purchaser.

Glaxo Pays For Chantix Woes

The Pharma company fights to separate itself from the competition's bad rep.

Broken Biovail May Be Irreparable

If ex-head Melnyk loses court challenge to board, he'll start a new company.

Biovail Founder Wants His Way

If Melnyk loses court challenge to board, he'll start a new company.